Eric P. Rahrmann

1.8k total citations · 1 hit paper
27 papers, 1.0k citations indexed

About

Eric P. Rahrmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Eric P. Rahrmann has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Neurology. Recurrent topics in Eric P. Rahrmann's work include Sarcoma Diagnosis and Treatment (8 papers), Neurofibromatosis and Schwannoma Cases (7 papers) and Mesenchymal stem cell research (4 papers). Eric P. Rahrmann is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), Neurofibromatosis and Schwannoma Cases (7 papers) and Mesenchymal stem cell research (4 papers). Eric P. Rahrmann collaborates with scholars based in United States, United Kingdom and Hong Kong. Eric P. Rahrmann's co-authors include David A. Largaespada, Richard J. Gilbertson, Adrienne L. Watson, Benjamin D. Simons, Nancy Ratner, Margaret H. Collins, Branden S. Moriarity, Vincent W. Keng, Christopher L. Moertel and Kwangmin Choi and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Nature reviews. Cancer.

In The Last Decade

Eric P. Rahrmann

27 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancers make their own luck: theories of cancer origins

2023 117 citations Eric P. Rahrmann, Benjamin D. Simons et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric P. Rahrmann United States	15	613	222	185	170	134	27	1.0k
Seung Ah Choi South Korea	19	549 0.9×	66 0.3×	81 0.4×	85 0.5×	196 1.5×	52	957
Zhiguo Chen China	19	726 1.2×	356 1.6×	242 1.3×	40 0.2×	473 3.5×	41	1.4k
Ziqiang Yuan United States	23	970 1.6×	55 0.2×	119 0.6×	86 0.5×	221 1.6×	44	1.5k
Scott Troutman United States	18	713 1.2×	128 0.6×	70 0.4×	36 0.2×	138 1.0×	25	1.3k
Josephine C. Dorsman Netherlands	23	1.4k 2.4×	152 0.7×	74 0.4×	95 0.6×	297 2.2×	59	2.0k
Carrie A. Haipek United States	13	709 1.2×	353 1.6×	94 0.5×	42 0.2×	143 1.1×	16	1.2k
Danny A. Zwijnenburg Netherlands	17	641 1.0×	337 1.5×	74 0.4×	23 0.1×	303 2.3×	23	965
Emily J. Rendleman United States	22	1.5k 2.5×	56 0.3×	59 0.3×	80 0.5×	146 1.1×	29	1.7k
Stacy A. Marshall United States	23	1.8k 2.9×	53 0.2×	59 0.3×	85 0.5×	189 1.4×	26	2.0k

Countries citing papers authored by Eric P. Rahrmann

Since Specialization

Citations

This map shows the geographic impact of Eric P. Rahrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. Rahrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. Rahrmann more than expected).

Fields of papers citing papers by Eric P. Rahrmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric P. Rahrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. Rahrmann. The network helps show where Eric P. Rahrmann may publish in the future.

Co-authorship network of co-authors of Eric P. Rahrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eric P. Rahrmann. A scholar is included among the top collaborators of Eric P. Rahrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric P. Rahrmann. Eric P. Rahrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rahrmann, Eric P., et al.. (2024). Osteosarcoma: A comprehensive review of model systems and experimental therapies. Medical Research Archives. 12(11). 3 indexed citations

Rahrmann, Eric P., et al.. (2023). Cancers make their own luck: theories of cancer origins. Nature reviews. Cancer. 23(10). 710–724. 117 indexed citations breakdown →

Foley, Kieran, David Shorthouse, Eric P. Rahrmann, et al.. (2023). SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(1). 166867–166867. 1 indexed citations

Shorthouse, David, Lizhe Zhuang, Eric P. Rahrmann, et al.. (2023). KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomas. Life Science Alliance. 6(12). e202302124–e202302124. 4 indexed citations

Rahrmann, Eric P., David Shorthouse, Mariaestela Ortiz, et al.. (2022). The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nature Genetics. 54(12). 1827–1838. 38 indexed citations

Smeester, Branden A., Nicholas J. Slipek, Natalie Stratton, et al.. (2020). Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma. Molecular Cancer Therapeutics. 19(12). 2528–2541. 13 indexed citations

Smeester, Branden A., Nicholas J. Slipek, Emily J. Pomeroy, et al.. (2020). PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma. Bone. 136. 115353–115353. 28 indexed citations

Smeester, Branden A., Nicholas J. Slipek, Emily J. Pomeroy, et al.. (2019). SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. Oncogene. 39(5). 1049–1062. 12 indexed citations

Rahrmann, Eric P., Natalie K. Wolf, George M. Otto, et al.. (2018). Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma. Molecular Cancer Research. 17(2). 567–582. 14 indexed citations

10.

Das, Paramita, et al.. (2015). PTPS-02FOXR2: AN ONCOGENE IN MEDULLOBLASTOMA. Neuro-Oncology. 17(suppl 5). v179.2–v179. 1 indexed citations

11.

Rathe, Susan K., et al.. (2014). Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia. Scientific Reports. 4(1). 6048–6048. 28 indexed citations

12.

Moriarity, Branden S., Eric P. Rahrmann, Caitlin B. Conboy, et al.. (2014). Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells. PLoS ONE. 9(5). e96114–e96114. 25 indexed citations

13.

Rahrmann, Eric P., Branden S. Moriarity, George M. Otto, et al.. (2014). Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath Tumorigenesis. American Journal Of Pathology. 184(7). 2082–2098. 27 indexed citations

14.

Watson, Adrienne L., Eric P. Rahrmann, Branden S. Moriarity, et al.. (2013). Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance. Cancer Discovery. 3(6). 674–689. 76 indexed citations

15.

Rahrmann, Eric P., Adrienne L. Watson, Vincent W. Keng, et al.. (2013). Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nature Genetics. 45(7). 756–766. 108 indexed citations

16.

Keng, Vincent W., Eric P. Rahrmann, Adrienne L. Watson, et al.. (2012). PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Research. 72(13). 3405–3413. 67 indexed citations

17.

Sólyom, Szilvia, Adam D. Ewing, Eric P. Rahrmann, et al.. (2012). Extensive somatic L1 retrotransposition in colorectal tumors. Genome Research. 22(12). 2328–2338. 192 indexed citations

18.

Rahrmann, Eric P., Lara S. Collier, Todd P. Knutson, et al.. (2009). Identification of PDE4D as a Proliferation Promoting Factor in Prostate Cancer Using a Sleeping Beauty Transposon-Based Somatic Mutagenesis Screen. Cancer Research. 69(10). 4388–4397. 74 indexed citations

19.

Henson, Michael S., K. Jordan, Eric P. Rahrmann, et al.. (2006). Anin vitromodel of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets. Amyloid. 13(4). 250–259. 8 indexed citations

20.

Zeng, Lepeng, Eric P. Rahrmann, Qingsong Hu, et al.. (2006). Multipotent Adult Progenitor Cells from Swine Bone Marrow. Stem Cells. 24(11). 2355–2366. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact